Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin vs Uterine Artery Clamping for Cesarean Scar Niche Repair
NCT07446933Phase 2Completed
- Sponsor
- Zagazig University
- Start
- Mar 2024
- Primary completion
- Oct 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of vasopressin in cesarean scar defect (CSD), sponsored by Zagazig University. Started Mar 2024; status: completed.
02
Drugs
vasopressin
03
Conditions
cesarean scar defect (CSD)
Beyond the preview
Go deeper on NCT07446933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07446933.